A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out the effect of the investigational drug
NOV-205 on the level of hepatitis C virus in the blood and whether NOV-205 is well-tolerated
at different doses when taken by subjects with hepatitis C.